BrightSpring Health 株価情報 (NASDAQ: BTSG)

最新ニュース BrightSpring Health (NASDAQ:BTSG) 株価情報

BrightSpring Health

BrightSpring Health Services Inc is a home and community-based healthcare services platform, focused on delivering complementary pharmacy and provider services to complex patients. Its platform delivers clinical services and pharmacy solutions across Medicare, Medicaid, and commercially insured populations. Its segments include Pharmacy Solutions, Provider Service. and others. It generates the majority of its revenue from the Pharmacy Solutions segment.

BrightSpring Health Services, Inc. - Common Stock

BrightSpring Health Services Inc

BrightSpring Health Services, Inc. - Tangible Equity Unit

BTS GROUP HLDGS UNSP/ADR by BTS Group Holdings Public Company Ltd

BTS Group Holdings PLC

HC Wainwright &amp; Co. analyst Raghuram Selvaraju reiterates Cocrystal Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COCP#NASDAQ">COCP</a>) with a Buy and maintains $7 price target.

News

Price Target

Reiteration

Analyst Ratings

COCP

HC Wainwright & Co. Reiterates Buy on Cocrystal Pharma, Maintains $7 Price Target

Citigroup analyst Asiya Merchant maintains Seagate Tech Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STX#NASDAQ">STX</a>) with a Buy and raises the price target from $120 to $125.

Citigroup Maintains Buy on Seagate Tech Hldgs, Raises Price Target to $125

Deutsche Bank analyst David Begleiter maintains H.B. Fuller (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FUL#NYSE">FUL</a>) with a Buy and lowers the price target from $75 to $72.

Deutsche Bank Maintains Buy on H.B. Fuller, Lowers Price Target to $72

Citigroup analyst Andrew Kaplowitz maintains 3M (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMM#NYSE">MMM</a>) with a Neutral and raises the price target from $142 to $152.

Citigroup Maintains Neutral on 3M, Raises Price Target to $152

Industry partners to provide funding and data to support ACAT&#x2122; model improvements
Simulations Plus, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLP#NASDAQ">SLP</a>) ("Simulations Plus"), a leading provider of biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today announced that it has entered a new funded collaboration with the Enabling Technologies Consortium (ETC). This partnership is aimed at advancing in vitro-in vivo correlation (IVIVC) approaches for oral drug delivery and expanding the functionality of the GastroPlus platform.
The collaboration focuses on enhancing the predictive capabilities of the GastroPlus advanced compartmental absorption and transit (ACAT&#x2122;) model to support the development of immediate release (IR) oral drug products. Using data gathered from public sources and members of the ETC, physiologically based pharmacokinetics (PBPK) and biopharmaceutics modeling (PBBM) experts and software engineers at Simulations Plus will look to complete key objectives as defined by the partnership. These advancements, including implementation of novel product-particle size distribution (P-PSD) methodologies and enhanced food effect modeling features, will provide researchers with powerful tools to improve drug product development, reduce reliance on animal studies, and streamline regulatory submissions.

Biotech

General

Simulations Plus And Enabling Technologies Consortium Announce Strategic Collaboration To Advance GastroPlus Enhancements

Global

P&G CFO Says Organic Sales In China Declined 3% In Q2

WIIM

ROKU

Roku shares are trading higher after Netflix reported strong quarterly earnings.

HC Wainwright &amp; Co. analyst Robert Burns reiterates Atara Biotherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATRA#NASDAQ">ATRA</a>) from Neutral to Neutral.

ATRA

HC Wainwright & Co. Reiterates Neutral on Atara Biotherapeuticsto Neutral

United Airlines shares are trading higher after the company reported better-than-expected Q4 financial results.

IBKR

Interactive Brokers shares are trading higher following better-than-expected Q4 financial results.

Citigroup analyst Christopher Allen maintains Charles Schwab (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCHW#NYSE">SCHW</a>) with a Neutral and raises the price target from $80 to $85.

SCHW

Citigroup Maintains Neutral on Charles Schwab, Raises Price Target to $85

The Offering is expected to close on or about January 23, 2025, subject to the satisfaction of customary closing conditions.&nbsp;

MCTR

CTRL Group Prices $8M Initial Public Offering Of 2M Common Shares At $4/Share

RVSN

Rail Vision shares are trading higher after the company announced a binding MoU with Sujan Ventures to introduce its safety systems to the Indian railway market.

FCEL

FuelCell Energy shares are trading higher after the company announced plans to build a 7.4 MW fuel cell power plant in Hartford, Connecticut, expected to add over $160 million to its generation backlog.

HC Wainwright &amp; Co. analyst Robert Burns maintains ArriVent BioPharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVBP#NASDAQ">AVBP</a>) with a Buy and raises the price target from $36 to $39.

AVBP

HC Wainwright & Co. Maintains Buy on ArriVent BioPharma, Raises Price Target to $39

ALLY

Ally Financial shares are trading higher after the company reported better-than-expected Q4 financial results and announced it will divest its credit card unit to CardWorks.

Deutsche Bank analyst Steve Powers maintains Estee Lauder Cos (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EL#NYSE">EL</a>) with a Hold and lowers the price target from $80 to $78.

Deutsche Bank Maintains Hold on Estee Lauder Cos, Lowers Price Target to $78

Financing

IESC

IES Announced That It Has Amended And Restated Its Existing Credit And Security Agreement, Increasing The Commitment Amount Of The Revolving Credit Facility To $300M From $150M And Extending The Maturity Date To January 21, 2030 While Expanding The Size Of The Lending Group

Deutsche Bank analyst Steve Powers maintains PepsiCo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEP#NASDAQ">PEP</a>) with a Buy and lowers the price target from $184 to $178.

Deutsche Bank Maintains Buy on PepsiCo, Lowers Price Target to $178

Macquarie analyst Tim Nollen maintains Netflix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) with a Outperform and raises the price target from $965 to $1150.

NFLX

Macquarie Maintains Outperform on Netflix, Raises Price Target to $1150

Morgan Stanley analyst Erin Wright maintained a Buy rating on BrightSpring Health Services, Inc. (BTSG – Research Report) today and set a price tar...

Morgan Stanley Sticks to Its Buy Rating for BrightSpring Health Services, Inc. (BTSG)

Morgan Stanley analyst Erin Wright raised the firm's price target on BrightSpring Health (BTSG) to $20 from $19 and keeps an Overweight rating on t...

BrightSpring Health price target raised to $20 from $19 at Morgan Stanley

Mizuho raised the firm's price target on BrightSpring Health (BTSG) to $22 from $20 and keeps an Outperform rating on the shares in conjunction wit...

BrightSpring Health price target raised to $22 from $20 at Mizuho

Reports preliminary adjusted EBITDA of approximately $588M. Sees FY25 revenue of $11.5B-$12B, consensus $12.39B. Sees FY25 adjusted EBITDA of $540M...

BrightSpring reports preliminary FY24 revenue $11.2B-$11.3B, consensus $11.17B

BrightSpring Health (BTSG) announced it has entered into a definitive agreement to divest its Community Living business, namely ResCare Community L...

BrightSpring Health to divest Community Living business

BrightSpring divests community living business for $835M; raises FY24 revenue outlook

The latest update is out from BrightSpring Health Services, Inc. ( ($BTSG) ). On January 17, 2025, BrightSpring Health Services, through its subsid...

BrightSpring Health Divests Community Living to Sevita

Mizuho Securities analyst Ann Hynes has maintained their bullish stance on BTSG stock, giving a Buy rating on January 20. Ann Hynes has given her B...

BrightSpring Health Services, Inc. Receives Buy Rating from Ann Hynes Amid Strategic Divestiture and Positive Financial Outlook

Whit Mayo, an analyst from Leerink Partners, reiterated the Buy rating on BrightSpring Health Services, Inc. (BTSG – Research Report). The associat...

BrightSpring Health Services, Inc.: Strategic Divestiture Fuels Strong Buy Rating and Growth Outlook

BTIG analyst David Larsen maintained a Buy rating on BrightSpring Health Services, Inc. (BTSG – Research Report) today and set a price target of $2...

BTIG Keeps Their Buy Rating on BrightSpring Health Services, Inc. (BTSG)

BTSG

Press Releases

HAVEN HOSPICE ACQUIRED BY BRIGHTSPRING HEALTH SERVICES

KKR to Purchase of 11,619,998 Shares of BrightSpring Health Services Common Stock from Walgreens Boots Alliance

Health Care

Management

BrightSpring Health Services, Inc. Welcomes Dr. Steve Miller to Board of Directors

BrightSpring Health Services, Inc. to Announce Third Quarter 2024 Financial Results on November 1, 2024

Earnings

BrightSpring Health Services, Inc. Reports Third Quarter 2024 Financial Results and Increases Full Year 2024 Guidance

BrightSpring Health Services Announces CareMed Was Selected as a National Specialty Pharmacy Partner for Leqembi®

BrightSpring Health Services, Inc. to Participate in Two Upcoming Investor Conferences

BrightSpring Health Services Announces Onco360® Has Been Selected as a Partner for Several New Drugs

BrightSpring Health Services, Inc. Announced Refinancing of Term Loan B

BrightSpring Health Services, Inc. Enters into Definitive Agreement to Divest Community Living Business to Sevita; Reports Preliminary 2024 Financial Results and Provides 2025 Guidance Excluding Community Living

Addus HomeCare Corporation - Common Stock

Addus HomeCare

Agilon Health

Amedisys

AMN Healthcare Services

Astrana Health

Chemed

Cigna

CorVel

CVS Health

Quest Diagnostics Incorporated Common Stock

Quest Diagnostics

DaVita

Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an Ordinary Share)

Comments

BrightSpring Health

ニュース

最新ニュース BrightSpring Health (NASDAQ:BTSG) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル